Indonesia-based health-tech firm Bumame has announced the successful completion of a funding round led by Alpha JWC Ventures, with participation from 500 Global and Kopital Ventures.

This accelerates Bumame’s mission to transform into Indonesia’s leading comprehensive healthcare partner, delivering proactive, preventive care for all Indonesians while empowering individuals to take charge of their well being, Bumame said in a statement on Thursday.

The new funding will enable Bumame to accelerate its digital transformation and broaden its range of healthcare offerings.

By focusing on early detection, fast and accurate diagnostic results, and tailored health insights, the firm said it is empowering individuals to make informed decisions about their well-being.

The investment will also support the development of seamless, technology-driven customer experiences that reflect the company’s commitment to innovation and accessibility.

“This milestone marks the beginning of an exciting new chapter for Bumame,

“The trust we built during the pandemic laid a strong foundation, but this funding empowers us to go further,” said James Wihardja, Co-Founder and Chief Executive Officer of Bumame.

“We are not just a healthcare provider; we aspire to be a lifelong health partner for every individual in Indonesia,

“Our ultimate mission is to foster a healthier, more confident society by emphasizing proactive and preventive care,” he added.

Launched in 2020, Bumame is a comprehensive healthcare partner offering advanced diagnostics, proactive health screenings, and personalized health guidance.

The firm offers a diverse portfolio of healthcare services, ranging from routine health check-ups and advanced diagnostics to personalized health plans that guide individuals toward healthier lives.

It is noted that in 2024, Indonesia’s healthcare market was valued at approximately $50 billion, with an annual growth rate of 11 percent driven by the rising demand for modern, accessible healthcare solutions.

This rapidly expanding market highlights the critical need for a trusted partner like Bumame to redefine healthcare accessibility and affordability for all Indonesians.

As Indonesia’s healthcare landscape continues to evolve, Bumame said the firm is uniquely positioned to meet the growing demand for accessible, holistic healthcare solutions.

Through cutting-edge technology and patient-focused medical practices, the company said it is redefining the healthcare experience by making it more seamless, efficient, and personalized.

“This funding is a testament to Bumame’s bold vision and the trust it has earned from investors, partners, and communities,

“By prioritizing technology, proactive care, and high- quality products sourced from top principals with global standards, Bumame ensures that healthcare is not only accessible but also affordable for all Indonesians,” said Chandra Tjan, Co-Founder & General Partner, Alpha JWC Ventures.

Alpha JWC Ventures is an early to growth-stage Southeast Asian venture capital firm.

Its debut fund was launched in 2016 as Indonesia’s first independent and institutional early-stage venture capital fund.

The firm currently manages around $650 million asset under management (AUM) with 80+ active portfolio companies across Southeast Asia.

East Ventures, Forge Ventures invest in Indonesian AI firm Nexmedis